FDA issued a Warning Letter to Celltrion Inc. on 1/26/2018 as a result of this inspection.
FDA investigators audited the Celltrion - Yeonsu, Korea (the Republic of) facility and issued inspectional observations (via FDA 483) on 02 Jun 2017.
Product details
- Category: Human Drugs
- Inspection end: 02 Jun 2017
- Location: Yeonsu, Korea (the Republic of)
- FEI: 3005241015
